Stent maker Sahajanand Medical Tech files for Rs 1,500 crore IPO



Cardiac stent maker Sahajanand Medical Technologies has filed preliminary papers with regulator to raise Rs 1,500 crore through an initial share sale.


The comprises fresh issuance of equity shares worth Rs 410.33 crore and an Offer for Sale (OFS) of equity shares to the tune of Rs 1,089.67 crore by selling shareholders, according to the Draft Red Herring Prospectus (DRHP).





As part of the OFS, Samara Capital Holding will sell shares worth Rs 635.56 crore and Nhpea Sparkle Holdings B.V will offload shares valued at Rs 320.36 crore, among others.


At present, Samara Capital holds 36.59 per cent stake and NHPEA Sparkle Holding BV owns 18.44 per cent holding in the firm.


The company may consider a pre-IPO placement of equity shares aggregating up to Rs 185 crore. If such placement is undertaken, the fresh issue size will be reduced.


Proceeds from the fresh issue will be utilised to pay debt, to fund the working capital requirements of the company’s indirect foreign subsidiary, Vascular Innovations Co. Ltd, and for general corporate purposes.


The company is a leading medical devices player that researches, designs, develops, manufactures and vascular devices globally.


Currently, the company offers products that are used in interventional cardiology.


It operates three research and development facilities in Surat, Galway, Ireland and Nonthaburi, Thailand. Also, the company is in the process of setting up a new research, development and manufacturing campus in Hyderabad.


BofA Securities India, Edelweiss Financial Services, UBS Securities India and Axis Capital are the book running lead managers to the issue.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor





Source link

Share Market Today
Logo